ArticleToxins2025

Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder.

Muhammed A M Hammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.